Correction to “A Pt(IV) Pro-Drug Preferentially Targets Indoleamine-2,3-Dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy”

Journal of the American Chemical Society - United States
doi 10.1021/jacs.6b01316
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)